Background: Concurrent with the recent rise of the incidence in obesity, nonalcoholic fatty liver disease is increasingly prevalent in childhood. The aim of this study was to identify non-invasive biomarkers for liver steatosis in obese children and adolescents. Methods: We used a cross-sectional study to examine risk factors for liver steatosis in obese children and adolescents. Sixty-nine obese subjects aged 6−17 years were recruited. The diagnosis of liver steatosis was made by liver ultrasonography. Anthropometric, serum biochemical variables, and oral glucose tolerance tests were measured. Results: Thirty-eight (55.1%) subjects had liver steatosis. Elevated alanine aminotransferase levels ( > 30 IU/L in boys and > 19 IU/L in girls) were found in 27 (71.1%) of the 38 subjects with liver steatosis. In multivariate logistic regression analysis, liver steatosis was associated with waist circumference and the change of plasma glucose level before and after oral glucose tolerance testing (C-OGTT). For every 5 cm increase in waist circumference, there was an odds ratio of 1.391 for predicting liver steatosis (95% confidence interval: 1.009−1.916, p = 0.044). C-OGTT was the only laboratory variable that independently predicted liver steatosis, with an odds ratio of 1.198 (95% confidence interval: 1.022−1.404, p = 0.026) for each 5 mg/dL of increase. Conclusion: In this hospital-based sample of obese children and adolescents, liver steatosis was common. Liver steatosis was positively associated waist circumference and C-OGTT. These findings have implications for screening liver steatosis in obese children and adolescents.
Introduction
Non-alcoholic fatty liver disease (NAFLD) represents a spectrum of conditions that ranges from simple liver steatosis to potentially fatal steatohepatitis. 1 Reports of pediatric NAFLD in obese children have been increasing 2, 3 and include cases of cirrhosis 4−6 and liver transplantation. 7 Obesity is clearly associated with NAFLD, but only a subset of obese children develop the condition. A better understanding of associated risk factors is required to prevent pediatric patients at risk from developing NAFLD. Previous epidemiologic studies in children revealed that the associated risk factors are increased body mass index (BMI), older age, male gender, Hispanic ethnicity, and Asian race, especially in children of Filipino background. 8 Since obesity is the major risk factor for the development of NAFLD, the prevalence of the disease has risen along with the dramatic increase in pediatric obesity in the past few decades. In Taiwan, based on data from the Elementary School Children's Nutrition and Health Survey conducted in 2001−2002, the prevalence of obesity was estimated to be 12% among 6−12-year-olds. 9 Concurrent with the epidemic of childhood obesity, NAFLD is emerging as an important clinical condition in Taiwan. However, published literature that discusses this issue is limited.
Obesity and metabolic risk factors related to obesity are known to track from childhood into adulthood; 10 therefore, the detection of NAFLD in childhood may be fundamental to early intervention and development of primary prevention strategies for NAFLD in at-risk populations. The aim of the present study was to identify non-invasive biomarkers for liver steatosis in obese children and adolescents, such as sex, BMI, waist circumference, insulin resistance, plasma glucose level (fasting and 2 hours after glucose challenge), blood pressure, lipid profile, uric acid, and high sensitivity C-reactive protein (hsCRP). Histological examination of liver biopsy specimens is required for the definitive diagnosis of nonalcoholic steatohepatitis; 11 however, this procedure is invasive. Therefore, in this study, we used liver ultrasound as the diagnostic modality. We scored the ultrasonographic findings of the liver and diagnosed steatosis.
Materials and Methods

Study population
From February 2006 to April 2008, 69 obese children aged 6−17 years were enrolled from the pediatric clinic at Far Eastern Memorial Hospital. Obesity was defined as BMI > 95 th percentile with age-and gender-adjustment, according to the standard of the De partment of Health in Taiwan. 9 Diagnosis requires exclusion of other causes of chronic hepatitis including hepatitis B, hepatitis C, autoimmune hepatitis, and Wilson's disease. Alcohol intake is excluded on the basis of reported history. All participants' parents gave informed consent; the ethics committee at the Hospital approved this study.
Demographic data
At the time of clinic visit, data on the child's age, gender, BMI, waist circumference, family history (including diabetes), obesity, hyperlipidemia, hepatobiliary disease, and hypertension were obtained. BMI was calculated as weight (kg) divided by height (m) squared. Waist circumference was measured at the navel level at the end of a normal expiration.
Laboratory investigations
A venous blood sample was collected in the morning after fasting for 8 hours when the children were free of acute illness. Biochemical measurements were performed on fresh serum by Roche reagents (Roche Diagnostics, Indianapolis, IN, USA) as follows: alanine aminotransferase (ALT), aspartate aminotransferase (AST), γ -glutamyl-transpeptidase (GGT), fasting glucose, triglyceride, total cholesterol, highdensity lipoprotein (HDL) cholesterol, and uric acid. ALT was measured by Kinetic UV test on a Hitachi 7600 Analyzer (Hitachi, Tokyo, Japan). In this study, elevated ALT levels were defined using updated and gender-related cutoff values (ALT > 0.50 μkat/L for boys and > 0.32 μkat/L for girls). 12 The remaining serum was frozen at −80ºC. Assays for fasting insulin and hsCRP were performed using stored sera. Insulin levels were measured using chemiluminescence immunoassay (DPC, Los Angeles, CA, USA). Levels of hsCRP were measured using an immunonephelometry assay (Dade Behring Inc., Newark, NJ, USA).
Insulin resistance was measured by homeostasis model assessment of insulin resistance (HOMA-IR), which was defined as: HOMA-IR = (fasting insulin [pmol/L]) × (fasting glucose [mmol/L]/156.3). 13 This has been proved as a valid index in prepubertal and pubertal obese children. 14 An oral glucose-tolerance test was performed with the administration of 1.75 g of glucose per kilogram of body weight (maximal dose, 75 g). Impaired oral glucose tolerance was defined as a glucose level greater than 7.77 mmol/ L but less than 11.0 mmol/L at two hours (2-hour plasma glucose level [2-hr PG]). 15 C-OGTT was defined as the change in plasma glucose level before and after oral glucose tolerance testing.
Liver ultrasonography
All participants underwent an ultrasonographic study of the liver performed by one operator (the first author). The hand-carried machine used (EnVisor C; Royal Philips Electronics Inc., Amsterdam, Netherlands) was equipped with an 8−3.5 MHz curved linear array probe (C5040; Royal Philips Electronics Inc.).
Liver steatosis was defined as the presence of an ultrasonographic pattern consistent with the following criteria: (1) liver-kidney echo discrepancy;
(2) attenuated echo penetration and visibility of diaphragm; and (3) obscure hepatic vessel structures. Liver steatosis was scored by the above ultrasonographic features as described by Chan et al (Table 1 ). 16 To improve the positive predictive value of liver ultrasonography, we used a more strict threshold; thus, a score of ≥ 4 was defined as liver steatosis in this study.
Statistical analysis
The statistical software SAS (version 9.1; SAS Institute Inc., Cary, NC, USA) was used in data analysis. Qualitative variables were expressed as proportions and compared using the χ 2 test, continuous variables were expressed as mean ± SD and compared using the independent two-sample t test.
In addition to these univariate analyses, multivariate analyses were performed by fitting multiple logistic regression models to identify independent factors associated with liver steatosis. To ensure the quality of the results, the basic model-fitting techniques for (1) variable selection, and (2) goodnessof-fit (GOF) assessment were used in our regression analyses. Specifically, in the stepwise variable selection procedure, all the univariate significant and non-significant covariates (except AST, ALT and γ GT) were considered. The significance levels for entry and for stay were set to 0.15 or larger. Both the GOF measures, such as percentage of concordant pairs and adjusted generalized R 2 , and the GOF tests, such as deviance GOF test, Hosmer-Lemeshow test, and Pearson's χ 2 GOF test, were examined to assess the GOF of the fitted logistic regression model. Two-sided p < 0.05 was considered as statistically significant.
Results
Subject characteristics
A total of 69 obese subjects were recruited. The mean age was 11.5 years (range, 6.3−17.6 years); 53 participants (76.8%) were male; 38 (55.1%) had ultrasonographic liver steatosis; and 26 (49.1%) boys and 7 (43.8%) girls had elevated ALT levels. The mean BMI was 31.1 kg/m 2 , with a range of 23.2−44.8 kg/m 2 . Seven (10.1%) were hypertriglyceridemic (fasting triglyceride > 1.70 mmol/L), 12 (17.4%) had hypercholesterolemia (fasting total cholesterol > 5.18 mmol/L), 12 (17.4%) had low HDLcholesterol (HDL cholesterol < 1.04 mmol/L), 2 (2.9%) had hyperglycemia (fasting glucose > 6.11 mmol/L), 9 (13.0%) had hyperinsulinemia (fasting insulin > 138.9 pmol/L), and 26 (37.7%) had insulin resistance (defined by HOMA-IR > 2 16 ). Eight (13.0%) had impaired oral glucose tolerance; of note, two had a fasting plasma glucose level > 6.11 mmol/L and 2-hr PG > 11.1 mmol/L, compatible with the criteria for the diagnosis of diabetes. Both also had liver steatosis and elevated ALT levels. They were transferred to our endocrinology clinic for further management.
Factors associated with liver steatosis
Univariate analysis
The enrolled obese participants were divided into two categories according to the liver steatosis, as defined by ultrasonographic findings: 31 without liver steatosis and 38 with liver steatosis. Table 2 presents the demographic features, anthropometric measurements and laboratory data between participants with and without liver steatosis. More male and older-aged participants were found among those with liver steatosis. Participants with liver steatosis had a greater waist circumference, higher systolic and diastolic blood pressure, as well as higher ALT, AST and GGT levels. There were no significant differences between subjects with and without liver steatosis for BMI. The 2-hr PG level and C-OGTT were significantly higher in those with Markedly obscure vessel structures and unidentifiable vessel walls liver steatosis compared with those without liver steatosis. However, there was no difference in terms of impaired oral glucose tolerance (the 2-hr PG criterion of > 7.77 mmol/L). To further assess elevated ALT levels in subjects with liver steatosis, we analyzed the relationship between them. As depicted in Figure 1 , there was a significant difference between elevated ALT levels and liver steatosis ( p < 0.001). Among subjects without liver steatosis, the percentage of elevated ALT was 13.6% in boys and 22.2% in girls. In contrast, elevated ALT levels were prevalent among 74.2% of boys and 57.1% of girls with liver steatosis.
Multivariate analysis
We use multivariate logistic regression to identify independent factors for liver steatosis. Age was put in the final multivariate model to adjust for its effect on other independent variables. Similar to the results from univariate analysis, waist circumference and C-OGTT were selected as positive factors in the multivariate model. In contrast to the results from univariate analysis, sex and blood pressure were not selected as independent factors of liver steatosis in multivariate analysis. For every 5 cm increase in waist circumference, there was an odds ratio of 1.391 (95% confidence interval: 1.009− 1.916) for predicting liver steatosis. C-OGTT was the only laboratory variable that independently predicted liver steatosis with an odds ratio of 1.198 (1.022−1.404) for each 5 mg/dL (0.28 mmol/L) increase ( Table 3 ).
Discussion
In this hospital-based study, we demonstrated that the independent factors of liver steatosis in obese children and adolescents are waist circumference and C-OGTT. Age, sex and blood pressures are associated with NAFLD in univariate analyses, but not after adjustment for waist circumference and C-OGTT. Several NALFD studies 17 in adults have shown visceral adiposity to be more influential than BMI. In a recent pediatric study, Fishbein et al 18 showed a positive correlation between hepatic fat content and visceral adipose tissue using magnetic resonance imaging. Consistent with previous studies, we found waist circumference to be the more influential factor in liver steatosis than BMI. The rationale for using this factor in predicting liver steatosis is that it is a surrogate measure of central obesity and a known predictor of early and late metabolic complications of childhood obesity. 19, 20 In presence of central obesity, the increased amount of visceral adipose tissue is resistant to insulin and exhibits a greater lipolysis. Increased free fatty acid influx to the liver leads to fatty liver, which then worsens the hepatic insulin resistance, causing more fat accumulation in the liver, leading to a vicious cycle. 21, 22 Associations between insulin resistance and NAFLD have been found by previous studies of obese children. 6, 23 Insulin resistance is thought to be the key factor in NAFLD, leading to excess fatty acid accumulation in the liver. 24 In the present study, among the several biomarkers for glucose and insulin metabolism, we found C-OGTT to be the only independent risk factor, suggesting that C-OGTT was better for predicting liver steatosis than fasting plasma glucose, insulin, or HOMA-IR. Some studies have demonstrated a reduced oral glucose tolerance associated with fatty liver and rising ALT in children. 25 If this proves to be true, C-OGTT might be useful for screening and identifying obese children and adolescents who are at high risk for NAFLD. However, questions still remain regarding the cut-off point used as the criterion to define a risk threshold. Although C-OGTT was an independent predictor of liver steatosis, the 2-hr PG > 7.77 mmol/L, the currently defined cut-off point for impaired glucose tolerance, 15 was too high to identify all high-risk subjects for liver steatosis in our subjects. Thus, further research is needed to improve our understanding of these issues.
Several limitations existed in the present study. First, our study was cross-sectional in design; we were unable to confirm a cause-and-effect relationship between risk factors and liver steatosis. Second, the diagnostic modality used in this study was liver ultrasonography, which is limited in its ability to stage hepatic fibrosis in NAFLD. 26 Addi tional investigations should address whether waist circumference and C-OGTT are associated with different severity of NAFLD. Third, to limit the potential bias of falsepositive diagnosis, we selected an ultrasonographic score ≥ 4 as the criterion for liver steatosis in this study. As a result, individuals with mild liver steatosis might have been misclassified into the no liver steatosis group. Nevertheless, such misclassification would generally decrease the power to detect differences, rather than leading to bias toward a significant difference. Therefore, it is unlikely that this issue contributed to the positive findings.
In conclusion, liver steatosis is associated with waist circumference and C-OGTT in obese children and adolescents in Taiwan. The rapid-growing epidemic of NAFLD in obese children and adolescents emphasizes the need to identify subjects at highrisk before their full-blown presentation. Our findings could potentially be utilized to identify pediatric obese population who may benefit from screening for NAFLD. 
